Pharmaceutical industry sees slowing growth momentum


In the first three months, top pharmaceutical firms like DHG Pharmaceutical and Imexpharm Corp experienced a paradoxical situation as their revenue increased while profit dipped. —Vietnam News

HANOI: The pharmaceutical industry’s growth momentum faded in the first quarter of the year, as companies grappled with fluctuating and rising prices of raw materials and intensifying competition.

The industry is an essential sector that is typically less impacted by economic slowdowns. However, weak demand has posed challenges for the fast-growing industry in Vietnam.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Public Bank records net profit of RM1.82bil in 2Q, dividend of 10.5c/share
Proton targets 200,000 sales in 2026 as xEV share reaches 17%
UOB Malaysia completes Malaysia's first brokered MYOR-based interbank transaction with RHB, Maybank
Asian stocks hesitant before Nvidia, oil slips on Hormuz hopes
Oil prices slide 2% on Iran-Oman talks to reopen Strait of Hormuz
Corporate earnings to drive individual stock performance
Ringgit opens higher against US$ as US Treasury yields ease
Trading ideas: Geohan, MNRB, Asteel, Sorento, WCE, Khee San, Pestec, KLK, Sime Property, SunCon, Matrix, Zetrix, Batu Kawan, Guan Chong, Ajinomoto, Cahya Mata
NationGate to ride on higher production yields
Granite Asia nets US$500mil for private credit fund

Others Also Read